Back to Research Home
EFXEquifax Inc
Industrials · Research & Consulting Services · Large
$182.36−2.55%
As of 23 Oct 2026Mkt cap $21.8B
Stage 13
WAIT
Fundamentals
51.5/75
Technical
9.9/15
Independent
61.3/90
GCAE viewelevated earnings event risk blocks an independent BUY decision
Price
- 1M
- +22.6%
- 3M
- +2.8%
- 6M
- +5.7%
- 1Y
- −20.9%
Financials & valuation
Cached filing evidence · as of 2026-10-20
Valuation
- P/E
- 29.5xHist median 46.7x
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- 20.5x
- FCF yield
- 4.9%
Quality
- ROIC
- 8.5%
- Operating margin
- 18.0%
- FCF margin
- 18.7%
- Current ratio
- 0.6x
Growth
- Revenue growth
- +6.9%Latest FY YoY
- Revenue CAGR
- +5.4%
- EPS CAGR
- −3.0%
- FCF CAGR
- +7.0%
Capital
- Share-count trend
- +0.1%3Y annualised
- Net debt
- $4.9B3.0x OCF
Annual trend
- CAGR 2021–2025
- +5.4%
- Latest · 2025
- $6B
- YoY
- +6.9%
GCAE Research
- Quality Research
- NOT FLAGGED
- Acceleration Radar
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- NOT FLAGGED
Key takeaway
elevated earnings event risk blocks an independent BUY decision
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
- Next earnings · 2027-02-03
More details & evidence
Production decision
- Stage 13
- WAIT
- Technical state
- extended
- Rotation
- headwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-20
- Quality Research
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded